본문 바로가기
KERD
논문KCI 등재

분자학적 방법을 이용한 Carbapenemase-Producing Klebsiella oxytoca 검출

Carbapenemase-Producing Klebsiella oxytoca Detection Using Molecular Methods

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류기타자연과학

초록

Klebsiella pneumoniae carbapenemase (KPC)와 같은carbapenem 분해효소의 급속한 증가와 보급은 의료 관련 감염 분야 내에서 주요한 문제가 되었다. Carbapenemresistant Enterobacteriaceae (CRE) 감염을 치료하기 위한항생제는 거의 없으므로 내성의 박테리아 메커니즘의 확인은 감염 통제와 역학 연구에 매우 중요하다. 그러므로 KPC 균주를 검출하는 신속하고 효과적인 방법은 치료상의 실패를 피하고, 이러한 다제 내성세균의 유통을 방지 및 통제하는 대책으로 도입할 필요가 있다. 분석에 이용한 31균주에서 Acinetobacter spp. 7균주, Morganella morganii 6균주, Pseudomonas aeruginosa 5균주, Proteus mirabilis 5균주, Proteus vulgaris 1균주, Enterobacter cloacae 2균주, Enterobacter aerogenes 1균주, Klebsiella pneumoniae 1균주, Klebsiella oxytoca 1균주, Serratia marcescens 1균주, Escherichia coli 1균주를 확인하였다. 그람음성 간균이 분리된 검체의 빈도는 urine (35.5%), blood (19.4%), sputum (16.1%), pus (9.7%), ascitic fluid (9.7%), tracheal aspirates (6.5%), bile juice (3.2%) 순으로 나타났다. PCR 방법을 이용한 유전자분석 결과blaIMP, blaVIM, blaOXA-48 에서는 증폭이 확인된 균주가 없었으나, Klebsiella oxytoca 1 균주에서 blaKPC 유전자를 확인하였다. 결론적으로, PCR 방법을 이용한 진단법은 KPC를 정확하고신속하게 진단할 수 있으며, 그로 인해 병원 내 KPC의 전파방지를 위한 신속한 예방대책 수립이 가능하다 할 수 있다.

Abstract

The rapid increase and dissemination of carbapene mases, such as Klebsiella pneumoniae carbapenemase (KPC), has become a major problem within the field of healthcare-related infection. There are few antibiotics to treat carbapenem-resistant Enterobacteriaceae (CRE) infections, so the identification of resistant bacterial mechanisms is critical to initiate infection control and conduct epidemiological research. A rapid and effective method for detecting KPC-producing bacteria is needed to avoid therapeutic failures and introduce measures to prevent and control the dissemination of these multi-resistant bacteria. During the study period, 31 isolates (seven isolates of Acinetobacter spp., six isolates of Morganella morganii, five isolates of Pseudomonas aeruginosa, five isolates of Proteus mirabilis, one isolate of Proteus vulgaris, two isolates of Enterobacter cloacae, one isolate of Enterobacter aerogenes, one isolate of Klebsiella pneumoniae, one isolate of Klebsiella oxytoca, one isolate of Serratia marcescens and one isolate of Escherichia coli) were identified by the VITEK. Gram negative rod bacteria were the most frequently isolated from urine (35.5%), blood (19.4%), sputum (16.1%), pus (9.7%), ascitic fluid (9.7%), tracheal aspirates (6.5%) and bile juice (3.2%). Analysis using the PCR method identified the blaKPC gene in the K. oxytoca1 strain, but the blaIMP, blaVIM and blaOXA-48 genes are not amplified. In conclusion, diagnosis using the PCR method can accurately and quickly diagnose KPC, thus establishing quick preventive measures to prevent the spread of KPC in hospitals.

참고문헌 (36)

  1. Ventola CL, "The antibiotic resistance crisis: part 1: causes and threats", PT, 40, pp.277~283 (2015)
  2. Saswati Sengupta, "The multifaceted roles of antibiotics and antibiotic resistance in nature", Frontiers in Microbiology, 4 (2013), Frontiers Media SA[DOI]
  3. "Office of infectious disease antibiotic resistance threats in the United States" (2013)[URL]
  4. Jieun Kim, "Carbapenem-resistant Enterobacteriaceae in Korea", Hanyang Medical Reviews, 38(2), pp.99~102 (2018), Hanyang University College of Medicine (KAMJE)[DOI]
  5. "FAQs about choosing and implementing a CRE definition" (2015)[URL]
  6. Tacconelli E, "Discovery, research, and development of new antibiotics : the WHO priority list of antibiotic-resistant bacteria and tuberculosis", Lancet Infect Dis, 18, pp.318~327 (2018)[DOI]
  7. McCann E, "Carbapenem-nonsusceptible gram-negative pathogens in ICU and non-ICU settings in US hospitals in 2017: a multicenter study", Open Forum Infect Dis, 5, pp.ofy241~ (2018)[DOI]
  8. Potter RF, "The rapid spread of carbapenem-resistant Enterobacteriaceae", Drug Resist Updat, 29, pp.30~46 (2016)[DOI]
  9. Alina Iovleva, "Carbapenem-Resistant Enterobacteriaceae", Clinics in Laboratory Medicine, 37(2), pp.303~315 (2017), Elsevier BV[DOI]
  10. 이효진, "카바페넴 내성 장내세균: 최신지견과 치료전략", 대한의사협회지, 61(4), pp.281~289 (2018), 대한의사협회[DOI]
  11. Tamma PD, "Comparing the outcomes of patients with carbapenemase-producing and non-carbapenemase producing carbapenem-resistant Enterobacteriaceae bacteremia", Clin Infect Dis, 64, pp.257~264 (2017)[DOI]
  12. Matthew E. Falagas, "Deaths attributable to carbapenem-resistant Enterobacteriaceae infections", Emerging Infectious Diseases, 20(7), pp.1170~1175 (2014), Centers for Disease Control and Prevention (CDC)[DOI]
  13. Hauck C, "Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections", Clin Microbiol Infect, 22, pp.513~519 (2016)[DOI]
  14. Goodman KE, "Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae(CRE)", Expert Rev Anti Infect Ther, 14, pp.95~108 (2016)[DOI]
  15. Aires-de-Sousa M, "Epidemiology of carbapenemase-producing Klebsiella pneumoniae in a hospital, Portugal", Emerg Infect Dis, 25, pp.1632~1638 (2019)[DOI]
  16. van Duin D, "The global epidemiology of carbapenemase-producing Enterobacteriaceae", Virulence, 8, pp.460~469 (2017)[DOI]
  17. "2017 Guidelines for management of medical-related infectious diseases (VRSA/CRE)" (2017)[URL]
  18. 정석훈, "Prevalence and Molecular Characteristics of Carbapenemase-Producing Enterobacteriaceae From Five Hospitals in Korea", Annals of Laboratory Medicine, 36(6), pp.529~535 (2016), 대한진단검사의학회
  19. 안선영, "최근 4년간 한 대학병원에서 분리된 Carbapenemase 생성 Enterobacteriaceae의 분자 역학과 특성 분석", Annals of Clinical Microbiology, 19(2), pp.39~47 (2016), 대한임상미생물학회
  20. Thomas P. Lodise, "Development of a bedside tool to predict the probability of drug-resistant pathogens among hospitalized adult patients with gram-negative infections", BMC Infectious Diseases, 19(1), pp.718~ (2019), Springer Science and Business Media LLC[DOI]
  21. Vikas Gupta, "Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013–2017", BMC Infectious Diseases, 19(1), pp.742~ (2019), Springer Science and Business Media LLC[DOI]
  22. Clinical Laboratory Standards Institute, "Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement M100-S27", Clinical Laboratory Standards Institute, ~ (2017)
  23. Bonomo RA, "Carbapenemase-producing organisms : a global scourge", Clin Infect Dis, 66, pp.1290~1297 (2018)[DOI]
  24. Bora A, "Incidence of metallo-beta-lactamase producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in central Nepal", BMC Res Notes, 7, pp.557~ (2014)[DOI]
  25. Monteiro J, "Rapid detection of carbapenemase genes by multiplex real-time PCR", J Antimicrob Chemother, 67, pp.906~909 (2012)[DOI]
  26. D. Doyle, "Laboratory Detection of Enterobacteriaceae That Produce Carbapenemases", Journal of Clinical Microbiology, 50(12), pp.3877~3880 (2012), American Society for Microbiology[DOI]
  27. Rhee JY, "KPC producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea", Antimicrob Agents Chemother, 54, pp.2278~2279 (2010)[DOI]
  28. 배일권, "Detection of Carbapenemases in Clinical Enterobacteriaceae Isolates Using the VITEK AST-N202 Card", Infection and Chemotherapy, 47(3), pp.167~174 (2015), 대한감염학회
  29. 노경호, "Isolation of a Klebsiella pneumoniae Isolate of Sequence Type 258 Producing KPC-2 Carbapenemase in Korea", Annals of Laboratory Medicine, 31(4), pp.298~301 (2011), 대한진단검사의학회
  30. Jeong SH, "Clonal and horizontal spread of the bla OXA-232 gene among Enterobacteriaceae in a Korean hospital", Diagn Microbiol Infect Dis, 82, pp.70~72 (2015)[DOI]
  31. Garg A, "Molecular epidemiology & therapeutic options of carbapenem-resistant gram-negative bacteria", Indian J Med Res, 149, pp.285~289 (2019)[DOI]
  32. "Patients with NDM-producing carbapenem-resistant Enterobacteriaceae (CRE) reported to the Centers for Disease Control and Prevention (CDC) as of December 2017, by state" (2017)[URL]
  33. Jesús Rodríguez-Baño, "Treatment of infections caused by extended-spectrum- beta-lactamase-, AmpC-, and carbapenemase-producing Enterobacteriaceae", Clinical Microbiology Reviews, 31(2) (2018), American Society for Microbiology[DOI]
  34. Park JW, "Status of carbapenemase producing Enterobacteriaceae incidences in Korea, 2015-2016. Research report", Cheongju: Korea Centers for Disease Control and Prevention, 10, pp.1243~1247 (2017)
  35. Go EB, "Distribution of carbapenem-resistant Enterobacteriaceae (CRE) in Korea, 2017. Research report", Cheongju: Korea Centers for Disease Control and Prevention, 11, pp.1518~1522 (2018)
  36. Weiner LM, "Antimicrobial-resistant pathogens associated with healthcare-associated infections : summary of data reported to the national healthcare safety network at the Centers for Disease Control and Prevention, 2011–2014", Infect Control Hosp Epidemiol, 37, pp.1288~1301 (2016)[DOI]

관련 논문AI추천

임상검체에서 분리된 그람음성막대균으로부터 카바페넴 내성유전자 검출Byoung Seon Yang대한임상검사과학회 · 대한임상검사과학회지2022 · 제54권 제3호최근 4년간 한 대학병원에서 분리된 Carbapenemase 생성 Enterobacteriaceae의 분자 역학과 특성 분석김명숙, 김현수, 박은숙, 서영희, 성지연, 안선영, 용동은, 이경원, 종소리, 최준용, 하은진, 황연지대한임상미생물학회 · Annals of Clinical Microbiology2016 · 제19권 제2호카바페넴분해효소 생성 장내세균 검출을 위한 Multiplex PCR의 개발 및 평가김나영, 김선주, 김시현, 배일권, 송새암, 신정환, Joseph Jeong대한임상미생물학회 · Annals of Clinical Microbiology2019 · 제22권 제1호경남지역 종합병원에서 분리된 그람음성막대균으로부터 blaKPC 및blaNDM 유전자 검출박지애, 양병선대한임상검사과학회 · 대한임상검사과학회지2021 · 제53권 제1호Prevalence and Molecular Characteristics of Carbapenemase-Producing Enterobacteriaceae From Five Hospitals in Korea김재석, 김한성, 김현수, 박민정, 송원근, 신동훈, 신새암, 이승순, 정석훈, 홍준성대한진단검사의학회 · Annals of Laboratory Medicine2016 · 제36권 제6호RAPIDEC CARBA NP 검사의 Carbapenemase 생성 장내세균의 진단 수행능력 평가어영, 송원근, 유길성, 황규열대한임상미생물학회 · Annals of Clinical Microbiology2016 · 제19권 제3호

이 간행물의 다른 논문 (14건)